Sequence Bio: Dawn score and attention ranking
Sequence Bio scores 47 out of 100 on the Dawn Index, built from 4 signals. It ranks #3 of 43 in Drug Discovery and Delivery (YC), #45 of 137 in YC Summer 2019, #107 of 534 in Healthcare (YC), #1366 of 4224 in Y Combinator.
What drives the Sequence Bio Dawn score?
| Signal | Weight | Score (0 to 100) |
|---|---|---|
| Search scale | 20% | 8 |
| Search momentum | 20% | 90 |
| Site scale | 15% | 6 |
| Site momentum | 10% | 100 |
How does Sequence Bio compare in Drug Discovery and Delivery (YC)?
| Rank | Brand | Dawn score |
|---|---|---|
| 1 | Shasqi | 59 |
| 2 | Rosebud Biosciences | 50 |
| 3 | Sequence Bio | 47 |
| 4 | Atlas Discovery | 46 |
| 5 | Quinn | 42 |
| 6 | Nabla Bio | 41 |
| 7 | WhiteLab Genomics | 41 |
| 8 | b12 Labs | 41 |
Where do the numbers come from?
Search figures are Google search estimates for the brand and its products. Site figures are third-party traffic estimates. A Dawn score measures attention, not revenue.